15
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T5521 | Bropirimine | U-54461 | TLR |
Bropirimine (U-54461) (U-54461) is a biological response modifier that is thought to act through the induction of lymphokines. | |||
T2206 | Quadrol | N,N,N′,N′-Tetrakis(2-hydroxypropyl)ethylenediamine,EDTP,Edetol | Others |
Quadrol (EDTP) is an immunostimulant, accelerated wound healing. | |||
T4412 | Roquinimex | Linomide,LS2616,FCF89,ABR212616 | TNF |
Roquinimex (FCF89) (Linomide) is a quinoline derivative immunostimulant which increases NK cell activity and macrophage cytotoxicity; inhibits angiogenesis and reduces the secretion of TNF alpha. | |||
T15777 | Loxoribine | RWJ 21757,7-Allyl-8-oxoguanosine | Influenza Virus , TLR |
Loxoribine (RWJ 21757) is a guanosine analog. Loxoribine is an orally bioavailable and selective Toll-like receptor (TLR) 7 agonist. It has anti-viral and anti-tumor activities.Loxoribine is a potent new immunostimulant ... | |||
T5076 | L-Allothreonine | L-allo-Threonine | Others , Endogenous Metabolite |
L-Allothreonine (L-allo-Threonine) is an essential amino acid in humans. L-Allothreonine is abundant in human plasma, particularly in newborns. Severe deficiency of threonine causes neurological dysfunction and lameness ... | |||
T11412 | IPN60090 | GLS1-IN-1 | Others , transporter |
IPN60090 is a novel, potent, orally bioavailable, renal-type glutaminase (GLS1)-specific inhibitor with an IC50 value of 31 nM for GLS1. IPN60090 has potential anticancer and immunostimulant/immunomodulatory activity, se... | |||
T4120 | N-Methylsarcosine | N,N-Dimethylglycine,N,N-Dimethylaminoacetic acid,Dimethylglycine,DMG | Endogenous Metabolite |
N-Methylsarcosine (Dimethylglycine) is used as an athletic performance enhancer and immunostimulant. It is also used in the treatment of autism, epilepsy and mitochondrial disease. It is also employed as a biomarker of p... | |||
T25712 | LH 1 | LH-1,LH1 | |
LH 1 is an immunostimulant used in antitumor treatment. | |||
T81260 | Rolistobart | ||
Rolistobart is a humanized IgG4-κ monoclonal antibody targeting LILRB4/CD85k. It functions as an immunostimulant and antineoplastic agent [1]. | |||
T81928 | Lipustobart | PD-1/PD-L1 | |
Lipustobart is an IgG4-kappa humanized monoclonal antibody targeting PDCD1 (programmed cell death 1, PD1, PD-1, CD279), with immunostimulant and antineoplastic activity [1]. | |||
T81736 | Muzastotug | ||
Muzastotug is a humanized IgG1-kappa monoclonal antibody targeting CTLA4, functioning as an immunostimulant and antineoplastic [1]. | |||
T81124 | Sovipostobart | ||
Sovipostobart, an immunoglobulin G1-kappa monoclonal antibody targeting CTLA-4 in Homo sapiens, features a cleavable prodomain. This compound serves as both an immunostimulant and antineoplastic [1]. | |||
T81510 | Perenostobart | ||
Perenostobart, a humanized IgG4-κ monoclonal antibody targeting ENTPD1/CD39, serves as both an immunostimulant and an antineoplastic [1]. | |||
T82465 | Enlonstobart | ||
Enlonstobart is a humanized IgG4-κ monoclonal antibody targeting PDCD1, functioning as both an immunostimulant and antineoplastic agent [1]. | |||
T82613 | Danburstotug | STI-3031,IMC-001 | PD-1/PD-L1 |
Danburstotug (IMC-001), an immunostimulant and antineoplastic [1], is a humanized IgG1-lambda monoclonal antibody targeting CD274 (PDL1, B7 homologue 1, B7H1). |